Glycopryl FG Rota Cap: A High-Demand Respiratory Product for Your PCD Pharma Franchise

The Consistent Market for COPD and Asthma Medications

Understanding the Synergistic Action of Formoterol and Glycopyrrolate

Why Glycopryl FG is the Right Choice for Your B2B Pharma Portfolio

Quality, Efficacy, and Our Commitment to Your Success
How to Begin Your Monopoly Franchise in Respiratory Care

Glycopryl FG Rota Cap

Composition : Formoterol (6mcg) + Glycopyrrolate (25mcg) Rota Capsule

Dosage Form : Rota cap

Packaging Type : Bottle

Packaging : 15ml

Price : ₹1/-

Please Contact For Best Price

In the critical care segment of respiratory health, products that offer both efficacy and convenience are a goldmine. Glycopryl FG Rota Cap, a powerful combination of Formoterol (6mcg) and Glycopyrrolate (25mcg), is a best-in-class product for the long-term management of Chronic Obstructive Pulmonary Disease (COPD) and asthma. As a PCD pharma company, we recognize the consistent, high demand for such specialized products, making this a valuable asset for any pharma distributor or wholesaler.

  • Formoterol: A long-acting beta-agonist (LABA) that helps relax the muscles in the airways, making breathing easier.

  • Glycopyrrolate: A long-acting muscarinic antagonist (LAMA) that works by reducing the production of mucus and opening up the airways.

The combined action of these two compounds provides superior and long-lasting relief from respiratory symptoms. The Rota Capsule format ensures the medication is delivered efficiently via an inhalation device, making it a highly reliable and popular choice among pulmonologists and patients alike. This market trust translates into high sales volume for our PCD pharma franchise partners.

At Cafoli Lifecare, we are committed to providing our B2B pharma partners with high-quality, profitable products. Our Glycopryl FG Rota Cap is manufactured in state-of-the-art facilities with strict quality controls. By partnering with us, you gain access to a reliable supply of this essential medication and the comprehensive support needed to succeed in the wholesale pharma market. Choose this product to build a strong and reputable business in the respiratory segment.

Read More

About the Product

In the critical care segment of respiratory health, products that offer both efficacy and convenience are a goldmine. Glycopryl FG Rota Cap, a powerful combination of Formoterol (6mcg) and Glycopyrrolate (25mcg), is a best-in-class product for the long-term management of Chronic Obstructive Pulmonary Disease (COPD) and asthma. As a PCD pharma company, we recognize the consistent, high demand for such specialized products, making this a valuable asset for any pharma distributor or wholesaler.

  • Formoterol: A long-acting beta-agonist (LABA) that helps relax the muscles in the airways, making breathing easier.

  • Glycopyrrolate: A long-acting muscarinic antagonist (LAMA) that works by reducing the production of mucus and opening up the airways.

The combined action of these two compounds provides superior and long-lasting relief from respiratory symptoms. The Rota Capsule format ensures the medication is delivered efficiently via an inhalation device, making it a highly reliable and popular choice among pulmonologists and patients alike. This market trust translates into high sales volume for our PCD pharma franchise partners.

At Cafoli Lifecare, we are committed to providing our B2B pharma partners with high-quality, profitable products. Our Glycopryl FG Rota Cap is manufactured in state-of-the-art facilities with strict quality controls. By partnering with us, you gain access to a reliable supply of this essential medication and the comprehensive support needed to succeed in the wholesale pharma market. Choose this product to build a strong and reputable business in the respiratory segment.

Common side effects can include a headache, dry mouth, muscle cramps, and dizziness. Less common but more serious side effects can include chest pain, a rapid heart rate, or blurred vision. A paradoxical bronchospasm, where the airways constrict immediately after using the medication, is a rare but life-threatening side effect. If you experience this, stop using the product and seek immediate medical attention.

This product is a combination of two bronchodilators, formoterol and glycopyrrolate. It is used for the long-term, maintenance treatment of Chronic Obstructive Pulmonary Disease (COPD), including chronic bronchitis and emphysema. Formoterol helps to relax the muscles around the airways, making it easier to breathe, while glycopyrrolate reduces secretions in the airways. It is not intended to be used as a "rescue" medication for sudden, acute breathing problems.

The "Rota Cap" is a capsule that contains powder for inhalation, and it must not be swallowed. It should be used with a device called a Rotahaler or similar inhaler, which punctures the capsule and allows the powder to be inhaled. It is crucial to follow the instructions for use provided by your doctor or pharmacist. Rinse your mouth with water after each use to reduce the risk of oral fungal infections. Do not stop using the medication without consulting your doctor, even if you feel better, as this can worsen your condition. Inform your doctor if you have a history of heart problems, glaucoma, or trouble urinating before starting this medication.

Store the capsules in their original blister pack or foil pouch at room temperature, in a dry place, away from heat and direct light. Do not open the foil pouch until you are ready to use the capsule. Keep the medication out of the reach of children.

Get in Touch